Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men;Trombomodulina, czynnik von Willebranda i tkankowy aktywator plazminogenu w osoczu krwi otyłych kobiet i mȩżczyzn

Polski Merkuriusz Lekarski

Volumn 15, Issue 90, 2003, Pages 518-520

  Rość, Danuta ^a   Drewniak, Wanda ^b   Kinasz Rózycka, Irena ^c   Kulwas, Arleta ^a   Michalski, Arkadiusz ^a  

^a AM ^*  (Poland)

^b Szpital Wojewodzki J Biziela   (Poland)

^c Szpital Wojewodzki J Biziela   (Poland)

Author keywords

Obesity; Thrombomodulin; Tissue plasminogen activator; Von Willebrand factor

Indexed keywords

CITRIC ACID; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LIPID METABOLISM; MALE; OBESITY; PLASMA; SEX; STATISTICAL SIGNIFICANCE; THROMBOCYTE; VASCULAR ENDOTHELIUM; VOLUNTEER;

ADULT; AGED; ANTIGENS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 1642516244     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bombeli T., Mueller M., Haberli A.: Anticoagulant properties of the vascular endothelium. Thromb. Haemost., 1997, 77, 408-423.
2. Deguchi K. i wsp.: Study of cardiovascular risk factors and haemostatic molecular markers in elderly persons. Semin. Thromb. Hemost., 2000, 26, 23?27.
3. Ferri C. i wsp.: Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension, 1999, 34, 568-573.
4. Gensisni G.F., Comeglio M., Colella A.: Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur. Heart J., 1998, 19 (Suppl. A), A53-61.
5. Iwan-Ziȩtek I., Ziȩtek Z., Kotschy M.: Proces fibrynolizy w raku gruczołu krokowego. Pol. Tyg. Lek., 1996, 8, 107-109.
6. Komatsumoto S., Onoda A., Nara M.: Changes in the level of thrombomodulin with aging. Nippon Ronen Igakkai Zasshi, 1996, 33, 521-517.
7. Magriples U. i wsp.: Thrombomodulin - a new marker for placental abruption. Thromb. Haemost., 1999, 81, 32-34.
8. Moalic R.P. i wsp.: Comparative study of the fibrinolytic system in human fetuses and in pregnant women. Thromb. Res., 1991, 61, 489-499.
9. Ossei-Gerning N., Wilson I.J., Grant P.J.: Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb. Haemost., 1998, 79, 736-740.
10. de Pergola G. i wsp.: Increase both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int. J. Obes. Ralet. Metab. Disord., 1997, 21, 527-535.
11. Ruggieri Z.M.: Structure and function of von Willebrand factor. Thromb. Haemost., 1999, 82, 576-584.
12. Sadler J.E.: Thrombomodulin structure and function. Thromb. Haemost., 1997, 78, 392-395.
13. Sumiyoshi K. i wsp.: Increase in levels of plasminogen activator and type 1 plasminogen activator inhibitor in human breast cancer. Possible role in tumor progression and metastasis. Thromb. Res., 1991, 63, 59-71.
14. Takada A., Takada Y., Urano T.: The physiological aspects of fibrinolysis. Thromb. Res., 1994, 76, 1-34.
15. Takano S. i wsp.: Plasma thrombomodulin in health and disease. Blood, 1990, 76, 2024-2029.
16. Tanaka A. i wsp.: Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin. Chem., 1991, 37, 269-272.
17. Van Hinsberg V.W.M. i wsp.: Effect of thrombin on the production of plasminogen activators and PA-inhibitor-1 by human microvascular endothelial cells. Thromb. Haemost., 1987, 57, 148-154.
18. Yudkin J.S. i wsp.: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 972-978.
19. Zawilska K.: Postȩpy w diagnostyce wewna̧trznaczyniowej aktywacji fibrynolizy. Acta Haemat. Pol., 1995, 26, 33-37.
20. Zimmerman T.S., Ratnoff O.D., Powell AE.: Immunologic differentiation of classic hemophilia (Factor VIII deficiency) and von Willebrand's disease. With observations on combined deficiences of antihemophilic factor and proaccelerin (Factor V) and on acquired circulating anticoagulant against antihemophilic factor. J. Clin. Invest., 1971, 50, 244-254.